Tony Coles joins Bloomberg Baystate Business to discuss Yumanity Therapeutics and the company’s efforts to develop new medicines to treat CNS diseases (segment begins at 44:30)

Uncategorized

Tony Coles joins Bloomberg Baystate Business to discuss Yumanity Therapeutics and the company’s efforts to develop new medicines to treat CNS diseases (segment begins at 44:30)

https://www.bloomberg.com/news/audio/2019-05-01/baystate-business-the-wynn-decision-radio

A lipid-desaturating enzyme offers a new drug target for Parkinson’s disease

https://cen.acs.org/pharmaceuticals/neuroscience/lipid-desaturating-enzyme-offers-new/96/web/2018/12

Tony Coles comments on the environment for raising capital for neurodegenerative disease research

https://www.ft.com/content/8d0db012-cda0-11e7-b781-794ce08b24dc

Scientific co-founder, Dr. Vikram Khurana, published for investigation into protein misfolding biology and pathology

http://www.cell.com/cell/fulltext/S0092-8674(17)31307-7

Dr. Ken Rhodes, explains method of using yeast to understand the protein misfolding associated with neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS BioCentury

https://www.biocentury.com/bc-innovations/tools-techniques/2017-11-16/how-yeast-could-provide-new-targets-neurodegenerative-?utm_content=bufferb5df3&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

Yumanty scientist, Dr. Piotrowski, published for work demonstrating how yeast can accelerate target discovery

https://phys.org/news/2017-07-scientists-baker-yeast-medicines.html

A pharma executive shows moral leadership: Why Ken Frazier did the right thing

https://www.statnews.com/2017/08/15/ken-frazier-right-call/

Tony Coles speaks on CNBC’s Closing Bell about the future of drug discovery CNBC

https://www.cnbc.com/video/2017/01/31/fmr-onyx-ceo-responsibility-to-find-and-research-cures-doesnt-come-cheap.html

Yumanity scientific co-founders publish two papers in Cell Systems uncovering a genetic network for Parkinson’s

http://wi.mit.edu/news/archive/2017/new-clues-basis-parkinson-s-disease-and-other-synucleinopathies

Colleague, Friend, and Yumanity co-founder, Susan Lindquist, Passes at 67

http://www.yumanity.com/wp-content/uploads/2016/10/Lindquist_Yumanity.pdf